The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of BGB-B2033 (GPC3 x 4-1BB bispecific antibody) monotherapy in patients with selected advanced or metastatic solid tumors: First disclosure of clinical data.
 
Hong Jae Chon
Honoraria - AstraZeneca; BeiGene; Boryung; Bristol Myers Squibb; Eisai; MSD; Ono Pharmaceutical; Roche; Sanofi; Servier
Consulting or Advisory Role - Aptamer Science; AstraZeneca; BeiGene; Boryung; Bristol Myers Squibb; Eisai; IMBDx; MSD; Ono Pharmaceutical; Roche; Servier
Research Funding - BeiGene; Boryung; Dong-A ST; IMBDx; Roche
 
Jung Yong Hong
Honoraria - AstraZeneca; Bristol-Myers Squibb; Dong-A Socio; Menarini; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Eisai; Elevar Therapeutics; Handok; ImmuneOncia; Roche
 
Xueli Bai
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Edward Gane
Consulting or Advisory Role - Aligos Therapeutics; AusperBio; Gilead Sciences; Precision Biosciences; Roche Diagnostics Solutions; Tune Therapeutics
Speakers' Bureau - AbbVie
Research Funding - BMS (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Yabing Guo
No Relationships to Disclose
 
Tongsen Zheng
No Relationships to Disclose
 
Jianbing Wu
No Relationships to Disclose
 
Yao Huang
No Relationships to Disclose
 
Vivek Subbiah
Consulting or Advisory Role - AADi; Abbvie (Inst); Bayer (Inst); Foundation Medicine; Illumina; Incyte (Inst); Loxo/Lilly; Novartis (Inst); Pfizer (Inst); Pheon Therapeutics (Inst); Relay Therapeutics (Inst); Roche (Inst)
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Relay Therapeutics (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Other Relationship - Clinical Care Options; Medscape
 
Ghassan Abou-Alfa
Consulting or Advisory Role - Abbvie; Ability Pharma (I); Agenus (I); Alligator Bioscience (I); Amgen (I); Arcus Ventures (I); Astellas Pharma (I); Astellas Pharma (I); AstraZeneca; Autem Medical; Berry Genomics; BioNtech (I); Boehringer Ingelheim (I); Bristol-Myers Squibb/Medarex (I); Fibrogen (I); Ikena Oncology (I); Immuneering (I); Ipsen; J-Pharma; Merck Serono (I); Merus NV (I); Moma Therapeutics (I); Neogene Therapeutics (I); Novartis (I); Regeneron (I); Revolution Medicines (I); Roche/Genentech; Servier; Syros Pharmaceuticals (I); Tango Therapeutics (I); Tempus (I); Vector Health; Yiviva
Research Funding - Abbvie (Inst); Agenus (Inst); Amgen (Inst); Arcus Ventures (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Beigene (Inst); BioNtech (Inst); Bristol-Meyer Squibb (Inst); Bristol-Myers Squibb (Inst); Coherus Biosciences (Inst); Digestive Care (Inst); Elicio Therapeutics (Inst); Genentech/Roche (Inst); Helsinn Healthcare (Inst); J-Pharma (Inst); Revolution Medicines (Inst); Yiviva (Inst)
 
Xiyan Mu
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Zhaoyin Zhu
Employment - BeOne Medicines
 
Jiadong Zhou
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
Honoraria - BeOne Medicines
 
Hugh Giovinazzo
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
Patents, Royalties, Other Intellectual Property - BeOne Medicines Ltd
 
Rose Huang
Employment - BeOne Medicines
Other Relationship - BeOne Medicines
 
Tingbo Liang
No Relationships to Disclose